Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Immunome Inc (IMNM)

Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Immunome Inc 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 USA

www.immunome.com Employees: 118 P: 425-939-7410

Sector:

Medical

Description:

Immunome, Inc. is a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. Immunome, Inc. is based in Exton, United States.

Key Statistics

Overview:

Market Capitalization, $K 2,444,957
Enterprise Value, $K 2,301,607
Shares Outstanding, K 110,332
Float, K 101,847
% Float 92.31%
Short Interest, K 15,315
Short Float 16.70%
Days to Cover 6.25
Short Volume Ratio 0.74
% of Insider Shareholders 7.69%
% of Institutional Shareholders 44.58%

Financials:

Annual Sales, $ 9,040 K
Annual Net Income, $ -292,960 K
Last Quarter Sales, $ 4,020 K
Last Quarter Net Income, $ -43,400 K
EBIT, $ -224,610 K
EBITDA, $ -225,410 K

Growth:

1-Year Return 112.46%
3-Year Return 290.14%
5-Year Return -41.68%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.65 on 11/06/25
Next Earnings Date 03/18/26
Earnings Per Share ttm -2.64
EPS Growth vs. Prev Qtr -30.00%
EPS Growth vs. Prev Year 16.67%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

IMNM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -76.51%
Return-on-Assets % -66.31%
Profit Margin % -3,240.71%
Debt/Equity 0.00
Price/Sales 181.62
Price/Cash Flow N/A
Price/Book 7.40
Book Value/Share 3.09
Interest Coverage -7.89
60-Month Beta 2.32
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar